These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy. Yamada T; Chen CC; Yamada T Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251 [TBL] [Abstract][Full Text] [Related]
5. HIV outreach and substance abuse treatment for Latino drug users: Implications for program planning. Lundgren LM; Delgado M Eval Program Plann; 2008 Feb; 31(1):61-3. PubMed ID: 18222141 [No Abstract] [Full Text] [Related]
6. Forging strategic alliances to fill gaps in addiction treatment. Wainwright A Behav Healthc Tomorrow; 2005 Jun; 14(3):32-5. PubMed ID: 16173509 [No Abstract] [Full Text] [Related]
7. A profile of the substance abuse treatment industry: organization, costs, and treatment completion. Woodward AM; Raskin IE; Blacklow B Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082 [TBL] [Abstract][Full Text] [Related]
8. Organizational and client determinants of cost in outpatient substance abuse treatment. Beaston-Blaakman A; Shepard D; Horgan C; Ritter G J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043 [TBL] [Abstract][Full Text] [Related]
10. Addiction Research Centres and the Nurturing of Creativity. Substance abuse research in a modern health care centre: the case of the Centre for Addiction and Mental Health. Rehm J; Giesbrecht N; Gliksman L; Graham K; Le AD; Mann RE; Room R; Rush B; Tyndale RF; Wells S Addiction; 2011 Apr; 106(4):689-97. PubMed ID: 20491727 [TBL] [Abstract][Full Text] [Related]
11. Training in addiction medicine should be standardised and scaled up. Klimas J BMJ; 2015 Jul; 351():h4027. PubMed ID: 26220548 [TBL] [Abstract][Full Text] [Related]
12. [Integrated Public Foundation for Drug Addiction Treatment in Baranya County, Hungary]. Szemelyácz J Psychiatr Hung; 2008; 23(4):287-9; discussion 289. PubMed ID: 19115587 [No Abstract] [Full Text] [Related]
13. Treatment for substance abuse in Australia: a comparison of public and private programs. McNeese-Smith DK Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233 [TBL] [Abstract][Full Text] [Related]
14. Time to take ACTION. Fitzgerald M Behav Healthc; 2007 Sep; 27(9):34-5. PubMed ID: 18030886 [No Abstract] [Full Text] [Related]
15. The substance abuse treatment system in Rhode Island: an ecological view. Marshall RJ; Knapp S Med Health R I; 1999 Mar; 82(3):82-6. PubMed ID: 10193136 [No Abstract] [Full Text] [Related]
16. No margin, no mission. Mason K Behav Healthc; 2009 Apr; 29(4):26-7. PubMed ID: 19472582 [No Abstract] [Full Text] [Related]
17. Recent trends in adolescent substance use, primary care screening, and updates in treatment options. Fournier ME; Levy S Curr Opin Pediatr; 2006 Aug; 18(4):352-8. PubMed ID: 16914986 [TBL] [Abstract][Full Text] [Related]
18. Addiction in Singapore: changing patterns and evolving challenges. Peh AL; Lim YC; Winslow RM Singapore Med J; 2012 Jul; 53(7):435-7; quiz 438. PubMed ID: 22815010 [TBL] [Abstract][Full Text] [Related]
19. Substance misuse: what place for women-only treatment programs? Weisner C Addiction; 2005 Jan; 100(1):7-8. PubMed ID: 15598183 [No Abstract] [Full Text] [Related]
20. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment. Ettner SL Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917 [No Abstract] [Full Text] [Related] [Next] [New Search]